Shanthi Ranganathan has submitted a formal declaration to the stock exchanges and the Audit Committee of TTK Healthcare Limited, confirming that she has not created any encumbrance on her shareholding during the financial year 2025-26. The declaration was made under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The declaration, dated April 01, 2026, was addressed to BSE Limited, National Stock Exchange of India Limited, and the Audit Committee of TTK Healthcare Limited. Ranganathan confirmed that she had not made any encumbrance on her holding of 58,360 Equity Shares of Rs. 10/- each in the company, either directly or indirectly during the specified financial year.

Declaration Details

The declaration was submitted from Ranganathan's address at No.6, Cathedral Road, Chennai 600 086. The communication requested the exchanges and the Audit Committee to take the information on record. Regulation 31(4) of the SEBI Takeover Regulations requires disclosures regarding any encumbrance created on shares held by persons who are required to make disclosures under the regulations.

TTK Healthcare Limited has submitted its mandatory regulatory compliance certificate for the quarter ended March 31, 2026, in accordance with SEBI (Depositories and Participants) Regulations, 2018. The submission demonstrates the company's commitment to maintaining regulatory compliance and transparency in securities handling processes.

Regulatory Compliance Details

The certificate was submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, dated April 02, 2026. This quarterly compliance requirement ensures proper handling of securities dematerialization processes and maintains investor protection standards.

Registrar and Transfer Agent Certification

Data Software Research Co. Pvt. Ltd., Chennai, serving as TTK Healthcare's Registrar and Share Transfer Agent, issued the compliance certificate. The certification confirms adherence to dematerialization requirements and proper securities handling procedures.

The certificate specifically confirms two critical compliance aspects:

• Securities comprised in the certificates have been listed on stock exchanges
• Certificates have been duly verified, mutilated, cancelled, and depository names substituted in records as registered owners

Regulatory Submissions

TTK Healthcare submitted the compliance documentation to multiple regulatory bodies and market infrastructure institutions to ensure comprehensive regulatory adherence.

The submission was signed by Gowry A Jaishankar, DGM – Legal & Company Secretary, with digital signature authentication dated April 02, 2026. This quarterly compliance certificate submission reflects TTK Healthcare's ongoing commitment to regulatory transparency and proper securities management practices, ensuring investor confidence and regulatory adherence.